Hepburn M - Search Results

1

Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases.

Blackman MA, Marchionni MA, Gilly J, Hepburn M, Innis BL, Barrett ADT, Kester KE, Mascola JR, Cummings JF, Monath TP, Cassetti MC, Kim JH, Saville M, Thomas SJ. Blackman MA, et al. Among authors: hepburn m. Vaccine. 2019 Oct 8;37(43):6248-6254. doi: 10.1016/j.vaccine.2019.08.061. Epub 2019 Sep 6. Vaccine. 2019. PMID: 31500964 Free PMC article.

2

The COVID-19 Serology Studies Workshop: Recommendations and Challenges.

Lerner AM, Eisinger RW, Lowy DR, Petersen LR, Humes R, Hepburn M, Cassetti MC. Lerner AM, et al. Among authors: hepburn m. Immunity. 2020 Jul 14;53(1):1-5. doi: 10.1016/j.immuni.2020.06.012. Epub 2020 Jun 23. Immunity. 2020. PMID: 32610080 Free PMC article.

3

Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses.

Dyson EH, Simpson AJH, Gwyther RJ, Cuthbertson H, Patient DH, Matheson M, Gregg A, Hepburn MJ, Hallis B, Williamson ED. Dyson EH, et al. Among authors: hepburn mj. Vaccine. 2022 Oct 6;40(42):6163-6178. doi: 10.1016/j.vaccine.2022.08.052. Epub 2022 Sep 22. Vaccine. 2022. PMID: 36153153 Clinical Trial.

4

Generation of heterogeneous memory T cells by live attenuated tularemia vaccine in humans.

Salerno-Gonçalves R, Hepburn MJ, Bavari S, Sztein MB. Salerno-Gonçalves R, et al. Vaccine. 2009 Dec 10;28(1):195-206. doi: 10.1016/j.vaccine.2009.09.100. Epub 2009 Sep 30. Vaccine. 2009. PMID: 19799845 Free PMC article.

5

Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine.

Hepburn MJ, Kortepeter MG, Pittman PR, Boudreau EF, Mangiafico JA, Buck PA, Norris SL, Anderson EL. Hepburn MJ, et al. Vaccine. 2006 Apr 5;24(15):2843-9. doi: 10.1016/j.vaccine.2005.12.055. Epub 2006 Jan 18. Vaccine. 2006. PMID: 16494976

6

A Diagnostic Platform Predicts Presymptomatic Exposure to Respiratory Viral Infection.

Zamisch M, Hepburn MJ, Ling GS. Zamisch M, et al. Among authors: hepburn mj. Mil Med. 2016 Mar;181(3):195-7. doi: 10.7205/MILMED-D-15-00481. Mil Med. 2016. PMID: 26926740 No abstract available.

7

Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.

Slaoui M, Hepburn M. Slaoui M, et al. Among authors: hepburn m. N Engl J Med. 2020 Oct 29;383(18):1701-1703. doi: 10.1056/NEJMp2027405. Epub 2020 Aug 26. N Engl J Med. 2020. PMID: 32846056 No abstract available.

8

Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine.

Hepburn MJ, Hugh Dyson E, Simpson AJ, Brenneman KE, Bailey N, Wilkinson L, Hornby R, Mateczun AJ, Bell MG, Baillie LW. Hepburn MJ, et al. Vaccine. 2007 Aug 10;25(32):6089-97. doi: 10.1016/j.vaccine.2007.05.018. Epub 2007 Jun 4. Vaccine. 2007. PMID: 17604880 Clinical Trial.

9

A Comparison of the Adaptive Immune Response between Recovered Anthrax Patients and Individuals Receiving Three Different Anthrax Vaccines.

Laws TR, Kuchuloria T, Chitadze N, Little SF, Webster WM, Debes AK, Saginadze S, Tsertsvadze N, Chubinidze M, Rivard RG, Tsanava S, Dyson EH, Simpson AJ, Hepburn MJ, Trapaidze N. Laws TR, et al. Among authors: hepburn mj. PLoS One. 2016 Mar 23;11(3):e0148713. doi: 10.1371/journal.pone.0148713. eCollection 2016. PLoS One. 2016. PMID: 27007118 Free PMC article.

10

Tularemia: current diagnosis and treatment options.

Hepburn MJ, Simpson AJ. Hepburn MJ, et al. Expert Rev Anti Infect Ther. 2008 Apr;6(2):231-40. doi: 10.1586/14787210.6.2.231. Expert Rev Anti Infect Ther. 2008. PMID: 18380605 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page